New Insights into Cholesterol Reduction and Dementia Risk
A recent study published in the journal “Alzheimer’s & Dementia,” led by Dr. Liv Tybjerg Nordestgaard, has uncovered new evidence suggesting that lowering cholesterol levels in the body can reduce the risk of developing dementia. The study was based on data from a variety of global sources, focusing particularly on the impact of genetic factors that influence cholesterol levels.
Genetic Evidence and Effects of Cholesterol Reduction
Research shows that some individuals are born with genetic variants affecting the same proteins targeted by cholesterol-lowering drugs such as statins and ezetimibe. The research team used a technique known as Mendelian randomization to study how these genetic variants can mimic the effects of treatment and reduce external influences like weight, diet, and lifestyle.
By comparing individuals with these genetic variants to those without, researchers observed a clear difference in dementia risk. A slight reduction in cholesterol levels (about one millimole per liter) was associated with up to an 80% reduction in dementia risk among certain drug-related genetic targets.
Cholesterol Reduction and Dementia Risk
Dr. Nordestgaard explained that the findings suggest individuals with genetic variants that lower cholesterol levels have a significantly reduced risk of developing dementia. These results propose that maintaining low cholesterol levels, whether through genetics or medical treatment, may protect against dementia.
However, the research does not yet confirm that cholesterol-lowering drugs themselves directly prevent the disease. This requires further research and long-term randomized studies.
Challenges in Studying Dementia
Studying the causes of dementia poses a significant challenge since the disease often develops in later stages of life, requiring participant follow-up over several decades. This makes it difficult to establish causal relationships in traditional clinical trials.
It remains unclear why high cholesterol increases dementia risk. One possible explanation is that high cholesterol contributes to atherosclerosis, a buildup of fats in blood vessels.
How High Cholesterol Harms the Brain
Dr. Nordestgaard explained that atherosclerosis results from cholesterol buildup in blood vessels, which can occur both in the body and the brain, increasing the risk of forming small blood clots, one of the causes of dementia.
She added that conducting randomized clinical trials over 10 or 30 years, where participants are given cholesterol-lowering drugs and then monitored for dementia risk, would be beneficial.
Conclusion
The study indicates a strong link between cholesterol levels and dementia risk, highlighting the importance of reducing cholesterol levels to prevent this disease. While more research is needed to confirm the effectiveness of cholesterol-lowering drugs in preventing dementia, these findings provide valuable insights into how genetic and chemical factors affect brain health. The global collaboration in this study underscores the importance of joint research and diverse contributions in uncovering new and important aspects of mental health.